… low bioavailability. The present study aimed to formulate lipid–polymer hybrid nanoparticles
(LPHNs) as carriers for the sustained release and oral bioavailability enhancement of TIL in …

… Enhancement of bioavailability of cytotoxic agents is a pre-requisite for successful …
bioavailability of VCR, we attempted to develop novel dextran sulphate-PLGA hybrid nanoparticles (…

… bioavailability. Herein, this investigation aimed to develop THQ-loaded lipid-polymer hybrid
nanoparticles (… Furthermore, the THQ-LPHNPs showed 4.74-fold enhanced bioavailability …

… data showed an enhancement (2.92 times more) in bioavailability in comparison to the …
hybrid nanoparticles could be a promising drug delivery option to enhance the bioavailability of …

… hybrid nanoparticles are efficient in enhancing dissolution rate and improving oral bioavailability
… presence of surfactant is critical for maximally enhanced in vitro dissolution rates and GI …

… After oral administration, RLX-bNPs resulted in significant enhancement in the bioavailability
of RLX, up to 556.9% relative to RLX suspensions, while it was merely 244.7% for RLX-…

… IBR)-loaded lipid-polymer hybrid nanoparticles (IBR-LPHNPs) to … The oral bioavailability of
IBR was improved 22.52-fold with … a promising approach to improve oral bioavailability of IBR. …

… bioavailability and anti-breast cancer efficacy of EXE. In this perspective, EXE-loaded
TPGS-based polymer lipid hybrid nanoparticles (… potential in improving oral bioavailability, safety, …

… QUE-cPLNs resulted in significantly enhanced bioavailability of QUE, up to 375.12%
relative to the formulation of suspensions. In addition, QUE-cPLNs exhibited excellent cellular …

… oral bioavailability of enoxaparin could be improved by lipid–polymer hybrid nanoparticles.
… is the precondition of oral absorption enhancement by nanoparticles. There are several …